Total Assets
Bristol-Myers Squibb Total Assets decreased by 4.0% to $86.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.4%, from $92.43B to $86.48B. Over 5 years (FY 2020 to FY 2025), Total Assets shows a downward trend with a -5.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Growth in total assets generally indicates business expansion, though it must be analyzed alongside debt levels to assess asset quality.
Detailed definition
This represents the aggregate value of all current and non-current assets owned by the company, including cash, inventor...
Peer comparison
Total assets for major pharmaceutical companies are heavily influenced by the valuation of acquired R&D pipelines and intellectual property.
total_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $110.80B | $110.89B | $109.31B | $103.03B | $100.36B | $98.20B | $96.82B | $94.28B | $93.49B | $91.26B | $95.16B | $99.03B | $94.65B | $93.67B | $92.60B | $92.43B | $94.68B | $96.89B | $90.04B | $86.48B |
| QoQ Change | — | +0.1% | -1.4% | -5.7% | -2.6% | -2.2% | -1.4% | -2.6% | -0.8% | -2.4% | +4.3% | +4.1% | -4.4% | -1.0% | -1.1% | -0.2% | +2.4% | +2.3% | -7.1% | -4.0% |
| YoY Change | — | — | — | — | -9.4% | -11.4% | -11.4% | -8.5% | -6.8% | -7.1% | -1.7% | +5.0% | +1.2% | +2.6% | -2.7% | -6.7% | +0.0% | +3.4% | -2.8% | -6.4% |
Total Assets at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's total assets?
- Bristol-Myers Squibb (BMY) reported total assets of $86.48B in Q1 2026.
- How has Bristol-Myers Squibb's total assets changed year-over-year?
- Bristol-Myers Squibb's total assets decreased by 6.4% year-over-year, from $92.43B to $86.48B.
- What is the long-term trend for Bristol-Myers Squibb's total assets?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's total assets has grown at a -5.3% compound annual growth rate (CAGR), from $118.48B to $90.04B.
- What does total assets mean?
- The sum of everything the company owns that has economic value.